Literature DB >> 23097035

First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival.

Wolfgang Otto, Stefan Denzinger, Wolf F Wieland, Arndt Hartmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23097035     DOI： 10.1007/s00345-012-0974-2

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  5 in total

Review 1.  Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review.

Authors:  Sven van den Bosch; J Alfred Witjes
Journal:  Eur Urol       Date:  2011-06-01       Impact factor: 20.096

Review 2.  Prognostic and predictive impact of intra- and peritumoral immune infiltrates.

Authors:  Wolf Herman Fridman; Jérôme Galon; Franck Pagès; Eric Tartour; Catheriné Sautès-Fridman; Guido Kroemer
Journal:  Cancer Res       Date:  2011-08-16       Impact factor: 12.701

3.  Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Authors:  Jérôme Galon; Anne Costes; Fatima Sanchez-Cabo; Amos Kirilovsky; Bernhard Mlecnik; Christine Lagorce-Pagès; Marie Tosolini; Matthieu Camus; Anne Berger; Philippe Wind; Franck Zinzindohoué; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

4.  FOXP3 and survival in urinary bladder cancer.

Authors:  Malin E Winerdal; Per Marits; Max Winerdal; Mudhar Hasan; Robert Rosenblatt; Anna Tolf; Katarina Selling; Amir Sherif; Ola Winqvist
Journal:  BJU Int       Date:  2011-01-18       Impact factor: 5.588

5.  The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder.

Authors:  M Hilmy; R Campbell; J M S Bartlett; A-M McNicol; M A Underwood; D C McMillan
Journal:  Br J Cancer       Date:  2006-10-03       Impact factor: 7.640
  5 in total
  12 in total

Review 1.  Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:  Shona Hendry; Roberto Salgado; Thomas Gevaert; Prudence A Russell; Tom John; Bibhusal Thapa; Michael Christie; Koen van de Vijver; M V Estrada; Paula I Gonzalez-Ericsson; Melinda Sanders; Benjamin Solomon; Cinzia Solinas; Gert G G M Van den Eynden; Yves Allory; Matthias Preusser; Johannes Hainfellner; Giancarlo Pruneri; Andrea Vingiani; Sandra Demaria; Fraser Symmans; Paolo Nuciforo; Laura Comerma; E A Thompson; Sunil Lakhani; Seong-Rim Kim; Stuart Schnitt; Cecile Colpaert; Christos Sotiriou; Stefan J Scherer; Michail Ignatiadis; Sunil Badve; Robert H Pierce; Giuseppe Viale; Nicolas Sirtaine; Frederique Penault-Llorca; Tomohagu Sugie; Susan Fineberg; Soonmyung Paik; Ashok Srinivasan; Andrea Richardson; Yihong Wang; Ewa Chmielik; Jane Brock; Douglas B Johnson; Justin Balko; Stephan Wienert; Veerle Bossuyt; Stefan Michiels; Nils Ternes; Nicole Burchardi; Stephen J Luen; Peter Savas; Frederick Klauschen; Peter H Watson; Brad H Nelson; Carmen Criscitiello; Sandra O'Toole; Denis Larsimont; Roland de Wind; Giuseppe Curigliano; Fabrice André; Magali Lacroix-Triki; Mark van de Vijver; Federico Rojo; Giuseppe Floris; Shahinaz Bedri; Joseph Sparano; David Rimm; Torsten Nielsen; Zuzana Kos; Stephen Hewitt; Baljit Singh; Gelareh Farshid; Sibylle Loibl; Kimberly H Allison; Nadine Tung; Sylvia Adams; Karen Willard-Gallo; Hugo M Horlings; Leena Gandhi; Andre Moreira; Fred Hirsch; Maria V Dieci; Maria Urbanowicz; Iva Brcic; Konstanty Korski; Fabien Gaire; Hartmut Koeppen; Amy Lo; Jennifer Giltnane; Marlon C Rebelatto; Keith E Steele; Jiping Zha; Kenneth Emancipator; Jonathan W Juco; Carsten Denkert; Jorge Reis-Filho; Sherene Loi; Stephen B Fox
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

2.  The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.

Authors:  T Horn; J Laus; A K Seitz; T Maurer; S C Schmid; P Wolf; B Haller; M Winkler; M Retz; R Nawroth; J E Gschwend; H R Kübler; J Slotta-Huspenina
Journal:  World J Urol       Date:  2015-06-09       Impact factor: 4.226

3.  Inflammatory-Related Genetic Variants in Non-Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment.

Authors:  Alexandra Masson-Lecomte; Evangelina López de Maturana; Michael E Goddard; Antoni Picornell; Marta Rava; Anna González-Neira; Mirari Márquez; Alfredo Carrato; Adonina Tardon; Josep Lloreta; Montserrat Garcia-Closas; Debra Silverman; Nathaniel Rothman; Manolis Kogevinas; Yves Allory; Stephen J Chanock; Francisco X Real; Núria Malats
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-06       Impact factor: 4.254

Review 4.  Is gender becoming relevant in uro-oncological research? A bibliographical analysis.

Authors:  Frank Kunath; Bastian Keck; Simone Bertz; Sabine Brookman-May; Matthias May; Daniel Vergho; Arndt Hartmann; Hubertus Riedmiller; Bernd Wullich; Maximilian Burger
Journal:  World J Urol       Date:  2013-04-09       Impact factor: 4.226

Review 5.  Immunotherapy in urothelial carcinoma: fade or future standard?

Authors:  Johannes Breyer; Maximilian Burger; Wolfgang Otto
Journal:  Transl Androl Urol       Date:  2016-10

6.  Generation of potent cytotoxic T lymphocytes against in male patients with non-muscle invasive bladder cancer by dendritic cells loaded with dying T24 bladder cancer cells.

Authors:  Eu Chang Hwang; Seung Il Jung; Hyun-Ju Lee; Je-Jung Lee; Dong Deuk Kwon
Journal:  Int Braz J Urol       Date:  2017 Jul-Aug       Impact factor: 1.541

7.  Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.

Authors:  Alexander C Dowell; Ellen Cobby; Kaisheng Wen; Adam J Devall; Vinnie During; Jane Anderson; Nicholas D James; Kar K Cheng; Maurice P Zeegers; Richard T Bryan; Graham S Taylor
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

8.  High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer.

Authors:  Sabine Hülsen; Eleonora Lippolis; Fulvia Ferrazzi; Wolfgang Otto; Luitpold Distel; Rainer Fietkau; Stefan Denzinger; Johannes Breyer; Maximilian Burger; Simone Bertz; Markus Eckstein; Annette Ebner; Arndt Hartmann; Carol-I Geppert
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

9.  Prognostic role of stromal tumor-infiltrating lymphocytes in locally advanced upper tract urothelial carcinoma: A retrospective multicenter study (TSU-02 study).

Authors:  Sida Cheng; Wenlong Zhong; Kun Xia; Peng Hong; Rongcheng Lin; Bo Wang; Xinfei Li; Junyu Chen; Zining Liu; Hongxian Zhang; Cheng Liu; Liefu Ye; Lulin Ma; Tianxin Lin; Xuesong Li; Jian Huang; Liqun Zhou
Journal:  Oncoimmunology       Date:  2021-01-04       Impact factor: 8.110

10.  Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer.

Authors:  Renate Pichler; Josef Fritz; Claudia Zavadil; Georg Schäfer; Zoran Culig; Andrea Brunner
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.